Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
75 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Wellcome Trust (Wellcome) is a charity funding research organization which offers funding services. The organization offers funding, grant management, education resources and investment services. It offers education services for PhD students, post-docs and clinicians, and also provides practical and interactive training in the biomedical laboratory techniques and data-analysis tools. Wellcome offers funding schemes to support individual researchers, teams and resources. The organization provides funds in areas of biomedical science, innovations, public engagement, humanities and social science; and other strategies.

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals include

  
Source:
Document ID
GDPH145425D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201662
Wellcome Trust, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201681
Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201691
Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016102
Wellcome Trust, Medical Devices Deals, 2010 to YTD 2016121
Wellcome Trust, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016135
Wellcome Trust, Pharmaceuticals &Healthcare, Deal Details1854
  Venture Financing181
    Cambridge Epigenetix Raises USD21 Million in Series B Financing182
    Freeline Therapeutics to Raise USD38 Million in Series A Financing201
    NightstaRx Raises USD35 Million in Series B Financing Round211
    Nabriva Therapeutics Raises USD120 Million in Series B Financing222
    Nightstar Raises Additional USD8.2 Million in Venture Financing Round241
    Autolus Raises USD45.4 Million in Series A Financing251
    14M Genomics Raises USD19.6 Million in Venture Financing261
    Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing271
    Kymab Raises USD40 Million in Series B Financing282
    Blue Earth Diagnostics Raises US$21.3 Million In Venture Financing301
    NightstaRx Raises US$19.8 Million In Venture Financing311
    Pcovery Raises USD4 Million in Venture Financing321
    Biocartis Raises US$40.5 Million In Series E Financing332
    Pcovery Raises USD5.7 Million in Seed Financing351
    Trino Therapeutics Raises US$12 Million In Series A Financing362
    Canbex Therapeutics Raises US$3 Million In Venture Financing382
    Radius Health Secures US$21.4 Million In Third Tranche Of Financing Round403
    Biocartis Secures US$96 Million In Series C Financing Round432
    Population Genetics Technologies Secures US$6 Million In Series B Financing452
    Cell Biosciences Secures US$20 Million In Series F Venture Financing472
    Kymab Raises US$25 Million In Series A Financing Round491
    Oxagen Raises US$33 Million In Series C Financing503
    Achaogen Raises US$56 Million In Series C Financing Round532
  Partnerships551
    Sigma-Aldrich Enters into Agreement with Sanger Institute551
    AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute561
    UCL Business Forms Joint Venture with Syncona571
    Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust581
    Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs592
    Illumina Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute611
    Horizon Discovery Enters Into Collaboration With Wellcome Trust Sanger Institute621
    Agilent Technologies Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute and Gencode631
    Department of Biotech Enters Into Co-Development Agreement With Wellcome Trust641
  Licensing Agreements651
    Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors652
    Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute671
  Acquisition681
    Ergomed Acquires Haemostatix682
    GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million702
Wellcome Trust - Key Competitors721
Key Employees731
Locations And Subsidiaries741
  Head Office741
  Other Locations &Subsidiaries741
Appendix751
  Methodology751
  About GlobalData751
  Contact Us751
  Disclaimer751

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Wellcome-Trust-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23060>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Wellcome-Trust-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23060>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research